Pharmadesc Spectrum is developed as an internationally peer reviewed journal to provide an unrestricted access in the fields of pharmacy and pharmaceutical sciences. The mission of the Pharmadesc Spectrum is to bring significant, enduring research to the scientific community in the field of Pharmaceutical sciences and clinical research. Pharmadesc Spectrum believes in its responsibility to safeguard the research and publish by providing high-quality review process and maintaining firm standards on data presentation and deposition.

Pharmadesc Spectrum goal is to help scientists to disclose their findings in the most efficient and effective way possible by keeping review times short. The heart of Pharmadesc Spectrum mission is the publication of original research in the form of articles, which represent top content in the journal and are highlighted with additional coverage.

The manuscripts submitted to Pharmadesc Spectrum that involve any extent of clinical trials conducted in human subjects should follow the ICMJE guidelines for conducting and reporting of clinical trials. All the case studies or clinical trial reports must follow guidelines for statistical analysis and reporting of trial results. The manuscripts submitted to Pharmadesc Spectrum that involve any extent of studies on animals, must have obtained the approvals for conducting animal toxicity studies from relevant ethical committees/authorities.